Guidance Archives - Page 77 of 637

2 minute read

Citizens Financial Broadly Affirms FY24 Forecast Post Mixed Q1 Results: Details

April 17, 8:05 AM

Citizens Financial Group Q1 FY24 revenue dips 7.9% YoY to $1.959B, missing estimates slightly. Net interest income falls 12% YoY to $1.44B due to lower loans. Adjusted net income down 32% YoY to $365M, but EPS beats at $0.79. CET 1 ratio improves to 10.6%.

CFG

2 minute read

What’s Going On With ASML Stock Wednesday?

By Anusuya Lahiri

April 17, 6:51 AM

ASML reports Q1 2024 net sales of €5.29B, down 21.6% YoY. Net bookings of €3.61B, proposes €6.10 dividend/share for 2023, and expects Q2 net sales of €5.7B-€6.2B.

ASML

1 minute read

Stellantis CEO Warns Of Challenging Year Amid Rising Prices: Report

By Shivani Kumaresan

April 17, 6:19 AM

Amidst rising pricing pressures, Stellantis CEO Carlos Tavares warns shareholders of a challenging year ahead. With elevated raw material costs and labor disputes, the carmaker navigates a fiercely competitive market.

STLA

1 minute read

Adidas Boosts Outlook On Strong Q1 Results: Details

By Shivani Kumaresan

April 17, 6:02 AM

Adidas AG reported preliminary results for the first quarter of 2024, with an 8% increase in currency-neutral revenues. In euro terms, revenues grew 4% to €5.458 billion in the quarter.

ADDYY

2 minute read

Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook

By Vandana Singh

April 16, 9:29 AM

Johnson & Johnson reports Q1 results: adjusted EPS $2.71 (up 12.4% Y/Y), sales $21.38B (up 2.3% Y/Y). Explore pharma giant's robust performance, including strong growth in Innovative Medicine and medical devices sales.

JNJ

2 minute read

Scilex Holding Preliminary Q1 Net Sales For ZTlido Were $12M-$13M; Q1 Gross Sales For ZTlido Were $34M-$38M; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses

By Benzinga Newsdesk

April 16, 9:08 AM

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute

SCLX

2 minute read

What’s Going On With PNC Financial Shares Today?

By Lekha Gupta

April 16, 8:51 AM

PNC reported lower Q1 FY24 results, with revenue declining 8% Y/Y. Net interest income fell 9% while noninterest income decreased 7%. Adjusted EPS was $3.36, above consensus.

IAT

2 minute read

Investors Cheer UnitedHealth’s Q1 Earnings Despite Cyberattack Fallout, Taking $872M Hit From Hack

By Vandana Singh

April 16, 7:56 AM

UnitedHealth shares rise on strong Q1 2024 results. Revenue beats expectations at $99.8B. Operating income at $7.9 billion includes $872 million cyberattack impact.

UNH